LIVER CANCER, ADULT
Clinical trials for LIVER CANCER, ADULT explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER, ADULT trials appear
Sign up with your email to follow new studies for LIVER CANCER, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial matches liver cancer treatment to Tumor's Fat-Burning signature
Disease control Not yet recruitingThis phase II trial tests a personalized approach for people with advanced liver cancer that cannot be removed by surgery. Researchers will classify each patient's tumor by its fatty acid degradation (FAD) subtype and assign either a drug combination (camrelizumab plus apatinib) …
Matched conditions: LIVER CANCER, ADULT
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Zapping liver cancer: electric pulses target tumors, spare healthy tissue
Disease control Not yet recruitingThis study tests a procedure called irreversible electroporation (IRE), which uses short electrical pulses to kill liver cancer cells while leaving nearby healthy tissue unharmed. It is for people with early-stage liver cancer (HCC) who have good liver function. The goal is to se…
Matched conditions: LIVER CANCER, ADULT
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Electric pulses zapping liver tumors: new hope for colorectal cancer patients?
Disease control Not yet recruitingThis study tests a procedure called irreversible electroporation (IRE), also known as Nanoknife, to treat liver tumors that have spread from colorectal cancer. IRE uses short electrical pulses to destroy cancer cells while sparing nearby blood vessels and bile ducts. The trial wi…
Matched conditions: LIVER CANCER, ADULT
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Liver surgery showdown: 15 vs 45 minutes of clamping – which is safer?
Knowledge-focused Not yet recruitingThis study looks at two different lengths of time for stopping blood flow to the liver during surgery for liver cancer. 600 adults will be randomly assigned to either a 15-minute or 45-minute pause in blood flow. The goal is to see if the longer pause is just as safe and does not…
Matched conditions: LIVER CANCER, ADULT
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC